Johnson & Johnson-backed Direct Flow Medical raised $32m, including $15m in debt from PDL BioPharma, as it seeks to advance its transcatheter device.
Direct Flow Medical, a US-based medical device producer backed by pharmaceutical firm Johnson & Johnson, secured $32m yesterday in a series D round.
The round comprised $17m in private equity from venture capital firm SV Life Sciences and an undisclosed second investor, as well as $15m in debt financing from healthcare patent holding company PDL BioPharma. The debt portion was the second tranche of a $50m debt facility.
Direct Flow has now raised approximately $109m in total, including $27m from…
